213 related articles for article (PubMed ID: 31102171)
1. MicroRNA Expression and Correlation with mRNA Levels of Colorectal Cancer-Related Genes.
Moghadamnia F; Ghoraeian P; Minaeian S; Talebi A; Farsi F; Akbari A
J Gastrointest Cancer; 2020 Mar; 51(1):271-279. PubMed ID: 31102171
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA Expression Levels and Histopathological Features of Colorectal Cancer.
Emami SS; Akbari A; Zare AA; Agah S; Masoodi M; Talebi A; Minaeian S; Fattahi A; Moghadamnia F
J Gastrointest Cancer; 2019 Jun; 50(2):276-284. PubMed ID: 29404790
[TBL] [Abstract][Full Text] [Related]
3. The role of miRNAs targeting K-ras and APC genes in colorectal cancer.
Yilmaz N; Yilmaz U; Tanbek K; Arikan S; Aksakal N; Zeybek U; Ergen A
Bratisl Lek Listy; 2020; 121(8):554-557. PubMed ID: 32726117
[TBL] [Abstract][Full Text] [Related]
4. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
5. The Role of MicroRNA Signature as Diagnostic Biomarkers in Different Clinical Stages of Colorectal Cancer.
Eslamizadeh S; Heidari M; Agah S; Faghihloo E; Ghazi H; Mirzaei A; Akbari A
Cell J; 2018 Jul; 20(2):220-230. PubMed ID: 29633600
[TBL] [Abstract][Full Text] [Related]
6. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
8. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
[TBL] [Abstract][Full Text] [Related]
10. Plasma miR-21: a potential diagnostic marker of colorectal cancer.
Kanaan Z; Rai SN; Eichenberger MR; Roberts H; Keskey B; Pan J; Galandiuk S
Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372
[TBL] [Abstract][Full Text] [Related]
11. Differential Expression of miR-20a and miR-145 in Colorectal Tumors as Potential Location-specific miRNAs.
Eslamizadeh S; Zare AA; Talebi A; Tabaeian SP; Eshkiki ZS; Heydari-Zarnagh H; Akbari A
Microrna; 2021; 10(1):66-73. PubMed ID: 33349227
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer.
Vishnubalaji R; Hamam R; Abdulla MH; Mohammed MA; Kassem M; Al-Obeed O; Aldahmash A; Alajez NM
Cell Death Dis; 2015 Jan; 6(1):e1614. PubMed ID: 25611389
[TBL] [Abstract][Full Text] [Related]
13. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological significance of microRNA-21 and miR-125 expression in colorectal cancer].
Zhang Y; Zhou ZG; Wang L; Zhang P; Wang MJ; Cui CF; Guan JT; Chen KL; Zhan L
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):623-6. PubMed ID: 19921579
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer.
Lai H; Zhang J; Zuo H; Liu H; Xu J; Feng Y; Lin Y; Mo X
Medicine (Baltimore); 2020 Feb; 99(9):e19265. PubMed ID: 32118734
[TBL] [Abstract][Full Text] [Related]
16. Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features.
Capodanno A; Boldrini L; Proietti A; Alì G; Pelliccioni S; Niccoli C; D'Incecco A; Cappuzzo F; Chella A; Lucchi M; Mussi A; Fontanini G
Int J Oncol; 2013 Sep; 43(3):765-74. PubMed ID: 23820752
[TBL] [Abstract][Full Text] [Related]
17. Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatment.
Ragusa M; Majorana A; Statello L; Maugeri M; Salito L; Barbagallo D; Guglielmino MR; Duro LR; Angelica R; Caltabiano R; Biondi A; Di Vita M; Privitera G; Scalia M; Cappellani A; Vasquez E; Lanzafame S; Basile F; Di Pietro C; Purrello M
Mol Cancer Ther; 2010 Dec; 9(12):3396-409. PubMed ID: 20881268
[TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
19. miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
Li J; Liang H; Bai M; Ning T; Wang C; Fan Q; Wang Y; Fu Z; Wang N; Liu R; Zen K; Zhang CY; Chen X; Ba Y
PLoS One; 2015; 10(6):e0130194. PubMed ID: 26061281
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.
Yau TO; Wu CW; Tang CM; Chen Y; Fang J; Dong Y; Liang Q; Ng SS; Chan FK; Sung JJ; Yu J
Oncotarget; 2016 Jan; 7(2):1559-68. PubMed ID: 26621842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]